Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
05 Feb 2021
Historique:
entrez: 10 2 2021
pubmed: 11 2 2021
medline: 11 2 2021
Statut: epublish

Résumé

The SARS-CoV-2 coronavirus responsible for the global pandemic contains a unique furin cleavage site in the spike protein (S) that increases viral infectivity and syncytia formation. Here, we show that O-glycosylation near the furin cleavage site is mediated by specific members of the GALNT enzyme family and is dependent on the novel proline at position 681 (P681). We further demonstrate that O-glycosylation of S decreases furin cleavage. Finally, we show that GALNT family members capable of glycosylating S are expressed in human respiratory cells that are targets for SARS-CoV-2 infection. Our results suggest that O-glycosylation may influence viral infectivity/tropism by modulating furin cleavage of S and provide mechanistic insight into the potential role of P681 mutations in the recently identified, highly transmissible B.1.1.7 variant.

Identifiants

pubmed: 33564758
doi: 10.1101/2021.02.05.429982
pmc: PMC7872346
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : Intramural NIH HHS
ID : Z01 DE000713
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DE000739
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIC DE000750
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

J Biol Chem. 2011 Apr 22;286(16):14493-507
pubmed: 21349845
Nature. 2020 Nov;587(7835):619-625
pubmed: 33208946
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Science. 2020 Nov 13;370(6518):861-865
pubmed: 33082294
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7296-301
pubmed: 24799692
Science. 2020 Sep 25;369(6511):1586-1592
pubmed: 32694201
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
J Biol Chem. 2013 Mar 8;288(10):6921-9
pubmed: 23329828
Nat Biotechnol. 2020 Aug;38(8):970-979
pubmed: 32591762
Nat Commun. 2018 Aug 29;9(1):3508
pubmed: 30158631
J Biol Chem. 2011 Nov 18;286(46):40122-32
pubmed: 21937429

Auteurs

Liping Zhang (L)

Developmental Glycobiology Section, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370.

Matthew Mann (M)

Section on Biological Chemistry, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370.

Zulfeqhar Syed (Z)

Developmental Glycobiology Section, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370.

Hayley M Reynolds (HM)

Developmental Glycobiology Section, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370.

E Tian (E)

Developmental Glycobiology Section, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370.

Nadine L Samara (NL)

Structural Biochemistry Unit, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370.

Darryl C Zeldin (DC)

Division of Intramural Research, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27514.

Lawrence A Tabak (LA)

Section on Biological Chemistry, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370.

Kelly G Ten Hagen (KG)

Developmental Glycobiology Section, NIDCR, National Institutes of Health, Bethesda, Maryland 20892-4370.

Classifications MeSH